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Abstract
Background: Inhalation of crystalline silica particles is in humans associated with inflammation and
development of fibrosis. The aim of the present study was to investigate the effect of crystalline
silica on the release of the fibrosis- and angiogenesis-related mediator FGF-2 and the pro-
inflammatory mediator IL-8, and how IL-1β and TNF-α were involved in this release from various
mono- and co-cultures of monocytes, pneumocytes and endothelial cells.
Results:  Silica exposure induced an increase of IL-8 release from monocytes and from
pneumocytes alone, and the FGF-2 level in the medium increased upon silica exposure of
pneumocytes. Both the responses were enhanced in non-contact co-cultures with endothelial cells.
The FGF-2 release seemed to increase with the silica-induced decrease in the number of
pneumocytes. The release of IL-8 and FGF-2 was partially suppressed in cultures with pneumocytes
in contact with monocytes compared to non-contact cultures. Treatment with anti-TNF-α and the
IL-1 receptor antagonist revealed that release of IL-1β, and not TNF-α, from monocytes dominated
the regulation of IL-8 release in co-cultures. For release of FGF-2, IL-1ra was without effect.
However, exogenous IL-1β reduced the FGF-2 levels, strongly elevated the FGF-2-binding protein
PTX3, and prevented the reduction in the number of pneumocytes induced by silica.
Conclusion: IL-1β seems to be differently involved in the silica-induced release of IL-8 and FGF-2
in different lung cell cultures. Whereas the silica-induced IL-8 release is regulated via an IL-1-
receptor-mediated mechanism, IL-1β is suggested only indirectly to affect the silica-induced FGF-2
release by counteracting pneumocyte loss. Furthermore, the enhanced IL-8 and FGF-2 responses
in co-cultures involving endothelial cells show the importance of the interaction between different
cell types and may suggest that both these mediators are important in angiogenic or fibrogenic
processes.
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Background
Chronic exposure to crystalline silica particles is associ-
ated with the development of silicosis and lung cancer in
humans. In the lung silica is phagocytosed by macro-
phages. This may cause cell damage and cell death, and
release of oxidants or proteases [1-3]. Attracted inflamma-
tory cells may release potentially toxic oxygen derivates
and proteolytic enzymes. This response will probably
cause further cellular damage and destruction of the extra-
cellular matrix [1].
Tumour necrosis factor (TNF)-α, interleukin (IL)-1β and
IL-8 are among the pro-inflammatory mediators found to
be released early in response to silica [4-6]. Both TNF-α
and IL-1β initiate immune responses and activate other
pro-inflammatory genes [7,8]. These mediators may indi-
rectly enhance cell proliferation or migration of some cell
types, contributing to tissue repair processes [9-12]. In
particle-induced inflammation both TNF-α and IL-1β
have been suggested as regulators of IL-8 [13,14]. IL-8 is a
chemokine acting as an important chemoattractant for
neutrophils that play an essential role in acute inflamma-
tion [15]. However, IL-8 also attracts other leucocytes
such as basophiles and macrophages and may participate
in angiogenic processes by affecting endothelial cell pro-
liferation [16].
Persisting inflammatory responses in the lung may lead to
the development of chronic inflammation, which may
result in tissue remodelling [17]. Both TNF-α and IL-1β
are implicated in the deposition of collagen during
incomplete lung tissue repair, which in turn may lead to
fibrosis [4,18,19]. Normal fibrotic activity may be charac-
terised as a rescue process of an injured organ and is initi-
ated early in the inflammatory process by the release of
growth factors regulating fibroblast activity [20,21]. The
fibroblast growth factor-2 (FGF-2) is released after tissue
injuries and during inflammation [22,23]. FGF-2 is
reported to be produced in lung epithelial cells, macro-
phages and endothelial cells [24-27] and to play a crucial
role during fibrosis as well as during angiogenesis
[26,28,29]. The multifunctional role is due to the varia-
tions in FGF receptors expressed in different cell types
[23,30]. FGF-2 stimulates the growth of cell types such as
fibroblasts, endothelial cells and osteoblasts [31-33] and
may be induced by IL-1 in different cell-types [32,34].
FGF-2 binds to several released and cell surface-expressed
molecules, including molecules in the extracellular matrix
[26]. A FGF-2 modulating protein Pentraxin 3 (PTX3) is a
glycoprotein synthesized in lung by monocytes, alveolar
epithelial cells and endothelial cells in response to inflam-
mation [27], and may locally be induced by the cytokines
IL-1β and TNF-α. During inflammation binding of PTX3
to FGF-2 may reduce the bioavailability of FGF-2, balanc-
ing the process of angiogenesis and fibrosis [26,35,36].
Interactions between different types of lung cells are initi-
ated early by the release of pro-inflammatory signals that
activate and regulate tissue cells and inflammatory cells,
and are crucial for the outcome of lung epithelial repair
[37,38]. Different co-culture models of lung cells have
revealed, despite their limitations, important information
about close cellular interactions and activation of signal-
ling pathways subsequent to particle exposure [39-41].
Lung macrophages and monocytes are target cells known
to be essential in coordinating the inflammatory response
to particles [14,42]. In lung inflammation monocytes
have been shown to migrate and accumulate in the alveo-
lar space [43-45], and play a role in particle clearance
[43,46]. Furthermore, monocytes are often causing
marked changes in the pattern of released inflammatory
mediators when interacting with epithelial lung cells. Co-
cultures of monocytes and lung epithelial cells may cause
enhanced release of pro-inflammatory cytokines com-
pared to monocultures of these cells after particle expo-
sure [13,39,40]. Interestingly, only re-organising the same
cell types from a contact into a non-contact co-culture,
amplified the release of some inflammatory mediators
[47,48].
Although a lot is known on mechanistic aspects of silica-
induced cell inflammation and fibrosis [3], the ability to
affect the endothelium is much less studied. Normally, sil-
ica will not come in contact with the endothelium, at least
not in the initial phase of exposure, in which the epithelial
lung barrier is intact. However, it is conceivable that silica
might affect the endothelium via indirect mechanisms,
involving macrophages/monocytes and pneumocytes.
Our aim in the present study was to examine the potential
of crystalline silica to induce the release of the pro-inflam-
matory chemokine IL-8 and the pro-fibrotic/pro-ang-
iogenic mediator FGF-2 in co-culture models involving
monocytes and/or pneumocytes in non-contact with
endothelial cells. In addition to determine the magnitude
of the responses, the focus was on the involvement of IL-
1β and TNF-α in IL-8 and FGF-2 responses and to study
the importance of the mutual interaction between the cell
types with respect to mediator release.
Results
The induction of IL-8 and FGF-2 release by crystalline sil-
ica was examined in monocultures of monocytes (M) and
pneumocytes (P), in contact co-cultures (M+P), in non-
contact co-cultures (M/P) and in non-contact doublet or
triplet co-cultures with endothelial cells (M/E, P/E, and
M+P/E). For experimental set-up, see Figure 1.Particle and Fibre Toxicology 2008, 5:16 http://www.particleandfibretoxicology.com/content/5/1/16
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IL-8 and FGF-2 release from lung cell co- and monocultures 
exposed to silica
IL-8
Crystalline silica induced an increase in IL-8 levels in all
cultures, statistically significant in P, M, M+P, M/P, M/E
and M+P/E. In particular the M/E co-culture, but also the
triplet co-culture M+P/E released high levels of IL-8 upon
silica exposure, indicating the influence of endothelial
cells. Since M/E induced higher IL-8 release than P/E, also
monocytes seem important for the IL-8 response (Figure
2A). However the response seemed reduced when pneu-
mocytes and monocytes were placed in proximity to each
other. Thus, the level of IL-8 in the exposed non-contact
co-culture M/E was significantly higher than M+P/E, M/P
and M+P, at the highest silica concentration.
FGF-2
Since silica particles are well known to cause prolonged
inflammation and fibrotic and angiogenic changes in
lung, the response of the cells with respect to the fibrosis-
and angiogenesis-related marker FGF-2 was investigated
(Figure 2B). Pneumocytes and endothelial cells were
important cells with respect to the FGF-2 response, since
pneumocytes alone and P/E co-cultures released signifi-
cantly increased levels of FGF-2 in response to silica. The
FGF-2 response in the P/E co-cultures was approximately
4-fold higher than in the pneumocytes alone. In the pres-
ence of silica monocytes alone did not release FGF-2. In
the proximity of monocytes, pneumocytes produced less
FGF-2. Still, an increase in FGF-2 response seemed to
occur in the triplet co-culture, in contrast to the M/E co-
culture, which did not respond to silica exposure. Silica
exposure did not induce a significant increase of FGF-2
release in M+P co-cultures in this set of experiments, but a
later set of experiments showed a significant increase in
silica-exposed M+P co-cultures. This variability for the
M+P results could be ascribed to undetectable levels of
FGF-2 in some of the insert experiments.
The figure shows how monocytes (M), pneumocytes (P) and endothelial cells (E) in different co-cultures are distributed into  compartments Figure 1
The figure shows how monocytes (M), pneumocytes (P) and endothelial cells (E) in different co-cultures are 
distributed into compartments.Particle and Fibre Toxicology 2008, 5:16 http://www.particleandfibretoxicology.com/content/5/1/16
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TNF-α and IL-1β release upon exposure to crystalline silica
It is known that the release of IL-8 may be induced by
both TNF-α and IL-1β [8,49]. The pneumocytes did not
release detectable levels of IL-1β or TNF-α in the absence
or presence of silica, and the presence of endothelial cells
did not seem to contribute to the silica-induced IL-1β or
TNF-α release in the co-cultures (data not shown). To
determine the influence of monocyte and pneumocyte
proximity, TNF-α and IL-1β levels were analysed in super-
natants of contact M+P and non-contact M/P co-cultures
after 43 h of silica exposure (Figure 3). Monocytes were
the main contributors to the TNF-α level with an approx-
imate 10-fold increase at the highest silica concentration
(data not shown). The levels in the M/P cultures did not
differ significantly from those in monocytes (data not
shown). In the contact co-cultures M+P, however, no sig-
nificant TNF-α release was observed even at the highest
concentration of silica (Figure 3A). Thus, the proximity of
epithelial cells to monocytes seemed to abolish the silica-
induced TNF-α release. For IL-1β, silica induced increased
levels in M/P co-cultures, and the levels were significantly
higher in the non-contact than in the contact M+P co-cul-
tures. Only in the M/P cultures the increase in IL-1β levels
The release of IL-8 and FGF-2 from monocultures and co-cultures of monocytes (M), pneumocytes (P) and/or endothelial cells  (E) Figure 2
The release of IL-8 and FGF-2 from monocultures and co-cultures of monocytes (M), pneumocytes (P) and/or 
endothelial cells (E). The cells were combined into non-contact co-cultures (M/P, M/E, and P/E) and contact co-cultures 
(M+P and M+P/E), and exposed to silica (80 and 160 μg/cm2) for 43 h. A: IL-8 (mean of max ± SE = 110583 ± 31940 pg/ml). B: 
FGF-2 (mean of max ± SE = 269 ± 134 pg/ml). ND = not detected. Data represent means ± SE for n = 4 – 5 separate experi-
ments. *P < 0.05 shows statistical differences of exposed cultures vs. controls. #P < 0.05 shows statistical differences of 
exposed non-contact co-cultures vs. contact co-cultures. ¤P < 0.05 in A shows statistical differences of exposed non-contact 
M/E vs. P/E co-cultures, and in B shows statistical differences of exposed non-contact co-cultures of P/E vs. P. Data for IL-8 
were log-transformed before performing ANOVA.Particle and Fibre Toxicology 2008, 5:16 http://www.particleandfibretoxicology.com/content/5/1/16
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The release of TNF-α and IL-1β in contact co-cultures (M+P) and non-contact co-cultures (M/P) Figure 3
The release of TNF-α and IL-1β in contact co-cultures (M+P) and non-contact co-cultures (M/P). The co-cultures 
were exposed to silica (80 and 160 μg/cm2) for 43 h. Data represent means ± SE for n = 3 separate experiments. *P < 0.05 
shows statistical differences of exposed co-cultures vs. control co-cultures. #P < 0.05 shows statistical differences of exposed 
contact co-cultures vs. exposed non-contact co-cultures. Data were log-transformed before performing ANOVA.Particle and Fibre Toxicology 2008, 5:16 http://www.particleandfibretoxicology.com/content/5/1/16
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due to silica exposure reached statistical significance (Fig-
ure 3B).
Effects of anti-TNF-α and/or IL-1 receptor antagonist on 
the release of IL-8 and FGF-2 from co-cultures
In order to study the role of TNF-α and IL-1β in the release
of IL-8 and FGF-2, different co-cultures (M+P, M/P, M+P/
E, P/E) were pre-treated with anti-TNF-α and IL-1 receptor
antagonist (IL-1ra), alone or in combination, and further
exposed to crystalline silica for 43 h.
IL-8
IL-1ra treatment significantly reduced the silica-induced
increase in IL-8 levels in all the three co-cultures that
included monocytes (Figure 4). In contrast, anti-TNF-α
reduced the IL-8 release significantly only in the triplet co-
culture M+P/E. Furthermore, the combined treatment
with anti-TNF-α and IL-1ra significantly reduced silica-
induced IL-8 to even lower levels than each of the inhibi-
tors alone. In the co-culture P/E the inhibitors did not
affect IL-8 release, neither alone nor in combination, indi-
cating that the silica effect in this co-culture was independ-
ent of TNF-α and IL-1β. Since IL-8 levels in this co-culture
were low, the results strengthen the assumption that
monocytes are important in the regulation of IL-8 release
in the co-culture systems.
FGF-2
In parallel to the IL-8 experiments alone, FGF-2 was meas-
ured after treatment of the different co-cultures (M+P, M/
The effect of anti-TNF-α (aTNF-α) and/or IL-1 receptor antagonist (IL-1ra) on IL-8 release Figure 4
The effect of anti-TNF-α (aTNF-α) and/or IL-1 receptor antagonist (IL-1ra) on IL-8 release. The contact and non-
contact co-cultures (M+P, M/P, M+P/E and P/E) were exposed to silica (160 μg/cm2) for 43 h. Contact is symbolised by "+" and 
non-contact by "/". Data represent means ± SE for n = 3 separate experiments. Mean of max ± SE = 27177 ± 1249 pg/ml. *P < 
0.05 shows statistical differences of co-cultures pre-treated with anti-TNF-α and/or IL-1ra vs. untreated co-cultures. #P < 0.05 
shows statistical differences of co-cultures pre-treated with anti-TNF-α or IL-1ra alone vs. co-cultures pre-treated with anti-
TNF-α and IL-1ra in combination. Data were log-transformed before performing ANOVA.Particle and Fibre Toxicology 2008, 5:16 http://www.particleandfibretoxicology.com/content/5/1/16
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P, M+P/E and P/E) with anti-TNF-α and IL-1ra. The antag-
onists, alone or in combination, did not cause any signif-
icant changes in the release of FGF-2 from any of the
silica-exposed cultures (Figure 5).
Changes in cell number in M+P and M/P co-cultures 
exposed to silica
Light microscopy of the cultures revealed a pronounced
reduction of adherent pneumocytes in the silica-exposed
mono- and contact co-cultures compared to un-exposed
controls at 43 h (Figure 6), but also as early as 20 h (data
not shown). In contact co-cultures silica-exposed pneu-
mocytes showed a significant reduction in cell number,
whereas no significant decrease of pneumocytes was
observed in non-contact co-cultures. The number of
monocytes was only significantly decreased in the non-
contact co-culture upon exposure to the highest concen-
tration of silica. These reductions in cell number seemed
to be due to cell death, since measurements of lactate
dehydrogenase (LDH) release to the medium showed a
significant increase after silica exposure in M+P compared
to M/P co-cultures (data not shown).
The effect of anti-TNF-α (aTNF-α) and/or IL-1 receptor antagonist (IL-1ra) on FGF-2 release Figure 5
The effect of anti-TNF-α (aTNF-α) and/or IL-1 receptor antagonist (IL-1ra) on FGF-2 release. The contact and 
non-contact co-cultures (M+P, M/P, M+P/E and P/E) were exposed to silica (160 μg/cm2) for 43 h. Contact is symbolised by "+" 
and non-contact by "/". Data represent means ± SE for n = 3 separate experiments. *P < 0.05 shows statistical differences of 
co-cultures pre-treated with anti-TNF-α and/or IL-1ra vs. untreated co-cultures. #P < 0.05 shows statistical differences of co-
cultures pre-treated with anti-TNF-α or IL-1ra alone vs. co-cultures pre-treated with anti-TNF-α and IL-1ra in combination. 
Data were log-transformed before performing ANOVA.Particle and Fibre Toxicology 2008, 5:16 http://www.particleandfibretoxicology.com/content/5/1/16
Page 8 of 18
(page number not for citation purposes)
Effect of IL-1β on release of IL-8, FGF-2, and cell number 
in M+P co-cultures
Since IL-1β seemed to play a more important role than
TNF-α in the release of silica-induced IL-8, the contact co-
culture M+P was supplied with new medium with and
without IL-1β prior to silica exposure, and examined for
changes in IL-8, FGF-2 and cell number (Figure 7).
IL-8
Relatively low levels (20 pg/ml) of IL-1α and IL-1β have
been found to affect the gene expression of IL-6 and IL-8
from pneumocytes [49]. Silica induced IL-1β levels in
M+P and M/P co-cultures that exceeded 20 pg/ml (data
not shown), supporting that IL-1β could be involved in
silica-induced release of IL-8. IL-1α, a ligand also acting
on IL-1R1 similar to IL-1β, was below the detection limit
in the exposed mono-and co-cultures (data not shown).
IL-8 levels increased with increasing IL-1β concentrations
(10 – 75 pg/ml) in M+P co-cultures. In Figure 7A only the
effect of 75 pg/ml of IL-1β on IL-8 release at 43 h is shown,
revealing a significantly enhanced IL-8 response to silica
exposure by IL-1β pre-treatment.
FGF-2
In the presence of IL-1β (75 pg/ml) the silica-induced
FGF-2 release was significantly decreased. A similar, but
non-significant effect was also observed for the basal FGF-
2 release (Figure 7B).
Cell number
In the presence of IL-1β (75 pg/ml) the loss of pneumo-
cytes exposed to crystalline silica was markedly reduced
compared to controls (Figure 7C).
Changes in FGF-2 relative to number of pneumocytes
The release of FGF-2 was reduced in the contact co-cul-
ture, M+P, compared to the non-contact co-culture and
monoculture of pneumocytes. Correlation analysis
showed a significant negative correlation between cell
numbers of silica-exposed pneumocytes and FGF-2
release in the contact co-cultures M+P (Figure 8A). This
suggests a relation between reduction in cell number and
FGF-2 release. When IL-1β was added the correlation
between FGF-2 release and cell numbers was less pro-
nounced, as visible by reduced FGF-2 level and by a shift
towards higher cell number in Figure 8B compared to 8A.
Silica-induced changes in numbers of monocytes and pneumocytes in contact co-cultures (M+P) and non-contact co-cultures  (M/P) Figure 6
Silica-induced changes in numbers of monocytes and pneumocytes in contact co-cultures (M+P) and non-con-
tact co-cultures (M/P). The co-cultures were exposed to silica (80 and 160 μg/cm2) for 43 h. Data represent means ± SE for 
n = 3 separate experiments. *P < 0.05 shows statistical differences of monocytes and pneumocytes in co-cultures exposed to 
silica vs. un-exposed co-cultures of these cells. Data were log-transformed before performing ANOVA.Particle and Fibre Toxicology 2008, 5:16 http://www.particleandfibretoxicology.com/content/5/1/16
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The effect of exogenous IL-1β on release of IL-8 (A) and FGF-2 (B) and on number of pneumocytes (C) Figure 7
The effect of exogenous IL-1β on release of IL-8 (A) and FGF-2 (B) and on number of pneumocytes (C). The 
contact co-cultures (M+P) were exposed to silica (160 μg/cm2) for 43 h. IL-1β (75 pg/ml) was added to the M+P co-culture 30 
min before silica exposure. Data represent means ± SE for n = 3 – 4 separate experiments. *P < 0.05 shows statistical differ-
ences of silica-exposed co-cultures vs. un-exposed controls. #P < 0.05 shows statistical differences of co-cultures exposed to 
silica vs. co-cultures given IL-1β before silica exposure. Arrows (A, B) indicate the direction of changes by exogenous IL-1β. 
Data for IL-8 and number of pneumocytes were log-transformed before performing ANOVA.Particle and Fibre Toxicology 2008, 5:16 http://www.particleandfibretoxicology.com/content/5/1/16
Page 10 of 18
(page number not for citation purposes)
The figure shows the correlation between changes in number of pneumocytes and FGF-2 release Figure 8
The figure shows the correlation between changes in number of pneumocytes and FGF-2 release. These changes 
were measured in un-exposed and silica-exposed contact co-cultures (M+P) without (A) and with IL-1β supply (B). The IL-1β 
(75 pg/ml) was added to the contact co-cultures 30 min before silica exposure (160 μg/cm2). The time of exposure was 43 h. 
Data are from 3 separate experiments. A high r2 indicates a good correlation. The slope was only significantly different from 
zero in figure A (P = 0.0183). Arrows (B) indicate the directions of changes (e.g. increased cell number and decreased release 
of FGF-2). Univariate linear regression and correlation analysis were used to assess if cell number could explain the changes in 
release of FGF-2.Particle and Fibre Toxicology 2008, 5:16 http://www.particleandfibretoxicology.com/content/5/1/16
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Changes in PTX3 levels
The data above suggest that the FGF-2 levels might be
attributed to silica-induced changes in cell number. Alter-
natively, changes in FGF-2-binding proteins might also
contribute to alterations in the FGF-2 levels. Figure 9A
shows that the protein PTX3, that is known to regulate
FGF-2 bioactivity by binding to the growth factor [27],
was markedly (3-fold) increased by exposure to silica
(160 μg/cm2) at 43 h. The PTX3 was also induced upon IL-
1β (75 pg/ml) treatment, with 2–3 fold higher responses
than for silica. No differences in PTX3 levels were detected
upon combined silica and IL-1β treatment compared to
IL-1β alone. The response to IL-1β with and without silica
was significantly reduced by IL-1ra treatment (Figure 9B).
Discussion
Silica-induced IL-8 release from pneumocytes and 
monocytes in co-cultures with endothelial cells
Variations of silica-induced release in TNF-α, IL-1β and IL-
8 have been demonstrated in different co-cultures,
depending on the use of primary cells vs. cell lines, cells
from different species or by differences in concentrations
or types of silica particles [39,48,50]. In the present study,
culturing endothelial cells in non-contact with mono-
cytes/pneumocytes showed strongly enhanced IL-8
responses compared to culturing these cells in the absence
of endothelial cells (Figure 2). This enhanced response
may be of importance for the effects of silica exposure in
vivo, since increased IL-8 levels may enhance angiogenic
processes [16].
Monocyte-derived IL-1β and regulation of IL-8 release 
from lung epithelial and endothelial cells in co-cultures
Both IL-1β and TNF-α are strong inducers of IL-8. The rel-
ative contribution may depend on the cell type
[13,49,51]. We have previously shown that both IL-1β
and TNF-α are released from monocytes upon silica expo-
sure, and that the dominant cytokine for IL-8 induction is
IL-1β [41]. The present results strengthen this notion,
since this result was the same for all co-cultures with
monocytes present. The absence of a requirement for TNF-
α in an inflammatory reaction and cytokine release has
also been observed in vivo in mice [52]. However, the
results with human lung cells seem to be inconsistent,
with two reports showing a predominant role for TNF-α
and one supporting the importance of IL-1β [13,14]. The
importance of TNF-α seems to be cell type-dependent,
since a marked inhibitory effect of anti-TNF-α on IL-8
release in the present study was observed in the triplet co-
culture. This may indicate that TNF-α and IL-1β at least
partly act via separate pathways in IL-8 regulation. The
importance of IL-1β was confirmed using exogenously
added cytokine to induce IL-8 in the contact-cultures (Fig-
ure 7A). Interestingly, IL-1β in maximal concentrations,
strongly increased the total release of IL-8 in both controls
and silica-exposed cultures, and did not alter the pattern
of amplified silica-induced IL-8 release compared to con-
trols. Possibly the IL-1β concentrations induced by silica
are not sufficient to saturate IL-1 receptors, allowing exog-
enous IL-1β to further augment the IL-8 synthesis in the
cells. Nevertheless, these results strengthen the role of
monocytes or macrophages as important coordinators of
the silica-induced inflammatory process in alveolar space.
In addition, the importance of endothelial cells in in vitro
studies is underlined; given the increased responses in co-
cultures that include endothelial cells. A previous study by
Herseth et al (2008) and in vivo studies show that cytokine
levels may fluctuate over time [41]. Whereas A549 in
monoculture responded to silica with steadily increasing
levels of cytokines over time [53], monocytes in monocul-
ture and in co-culture with endothelial cells exhibited a
similarly fluctuating pattern of cytokine levels, indicating
monocytes as the most important cell type for the varia-
tions over time. However, though these fluctuations in
vitro resemble what has been observed in vivo, other cell
types may play important roles in regulating the levels in
vivo.
Pneumocyte-dependent reduction of IL-1β, TNF-α and IL-
8 release in contact co-cultures with monocytes
The present study indicates that monocytes in contact co-
cultures with pneumocytes (M+P) release lower amounts
of TNF-α, IL-1β and IL-8 upon exposure to silica, com-
pared to non-contact co-cultures (M/P) (Figure 2 and 3).
The release of TNF-α and IL-1β in the contact co-cultures
M+P did not show any significant changes with increased
silica-concentrations, whereas a significant IL-8 response
was still retained. This is in accordance with a down-regu-
lation of TNF-α and IL-1β release observed in contact co-
cultures compared to non-contact co-cultures in a study
using rat cells [48]. In contrast, Tao et al. (2002) found a
cell contact-dependent increase of TNF-α release after sil-
ica exposure to rat alveolar macrophages and epithelial
type II cells [39]. Furthermore, contact co-culturing of
macrophages and rat and human epithelial lung cells
caused similar down-regulation of the inflammatory
marker nitric oxide (NO). These results underline the
importance of cellular interactions for cellular responses.
The reduced release of TNF-α and IL-1β in the contact co-
cultures is presumably not due to cytotoxicity in the
monocyte culture, since silica did not significantly reduce
the number of viable monocytes. This cell type contrib-
utes significantly to the levels of these cytokines. More
probable, surfactant released from pneumocytes in prox-
imity to monocytes may be of importance for the reduced
cytokine levels. Interestingly, Kanj et al. 2006 showed that
surfactant inhibited the release of TNF-α and IL-1β from
alveolar macrophages. Furthermore, a pneumocyte-mac-
rophage contact-dependent reduction in TNF-α level wasParticle and Fibre Toxicology 2008, 5:16 http://www.particleandfibretoxicology.com/content/5/1/16
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The effect of IL-1ra (A) and/or exogenous IL-1β (B) on the release of PTX3 in contact co-cultures (M+P) Figure 9
The effect of IL-1ra (A) and/or exogenous IL-1β (B) on the release of PTX3 in contact co-cultures (M+P). The 
co-cultures were exposed to silica (160 μg/cm2) for 43 h. IL-1β (75 pg/ml) was added to the M+P co-culture with or without 
IL-1ra 30 min before silica exposure. Data represent means ± SE for n = 3 separate experiments. *P < 0.05 shows statistical dif-
ferences of exposed co-cultures vs. un-exposed controls. #P < 0.05 shows statistical differences of exposed co-cultures treated 
with IL-1ra vs. exposed co-cultures without treatment. ¤P < 0.05 shows statistical differences of IL-1β-treated co-cultures vs. 
un-treated co-cultures. Data were log-transformed before performing ANOVA.Particle and Fibre Toxicology 2008, 5:16 http://www.particleandfibretoxicology.com/content/5/1/16
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observed under both basal and silica-exposed conditions.
Surfactant may also reduce the cytotoxicity of inhaled par-
ticles by surface coating of the particles [2,48]. Surfactant
proteins are known to be released from the human type II
alveolar cell line A549 [54,55], and silica exposure to
pneumocytes may increase the release of surfactant
[56,57]. However, other mediators might also be
involved, and the mechanisms of the pneumocyte-
dependent down-regulation of inflammatory response in
contact with macrophages/monocytes are still not com-
pletely understood [48]. The reductions in total IL-8 levels
may reflect a reduced TNF-α and IL-1β formation and not
a direct effect on the formation of IL-8, since TNF-α and
IL-1β are strong inducers of IL-8 [13,49,51]. It cannot be
excluded that the reduction in IL-8 level in contact co-cul-
tures might be due to an increase in the number of parti-
cle-exposed cells per cm2, (exposure of both monocytes
and pneumocytes compared to non-contact co-cultures
with exposure of only the monocytes), thereby reducing
the silica concentrations available per cell.
Silica-induced FGF-2 from pneumocytes alone and in co-
cultures with endothelial cells
FGF-2 is released after tissue injury and during inflamma-
tion [22,23], and is crucial in the development of lung
fibrosis. Furthermore, FGF-2 is known to be a potent fac-
tor in inducing angiogenesis that plays a key role in
inflammation and wound repair [26,58]. In the present
study, silica induced an increased release of FGF-2 from
pneumocytes. Previously, it has been reported that silica
induces FGF-2 release from bronchial epithelial cells [24].
In P/E co-cultures, both basal and silica-induced FGF-2
release were strongly enhanced, supporting an interaction
between these cell types, which may be of importance dur-
ing angiogenic processes (Figure 2B). The marked
response in the P/E co-cultures might either be due to a
production of endothelial cell-derived factors that stimu-
late the release of FGF-2 from the pneumocytes, or the
release of pneumocyte-derived factors that stimulate the
release of FGF-2 from the endothelial cells. Several publi-
cations report that endothelial cells both respond to and
release FGF-2 [26,59,60]. Possibly the silica-induced FGF-
2 release from the pneumocytes leads to a further release
of FGF-2 from the endothelial cells in P/E co-cultures,
since both paracrine and autocrine mechanisms for FGF-
2 release are known to occur in endothelial cells
[24,26,61]. Macrophages have also been reported to
secrete FGF-2 [25,62]. However, in the present study
monocytes did not release detectable FGF-2. This differ-
ence might be due to cell type-specific properties or
changes induced by immortalisation.
FGF-2 release: Inverse relationship to the number of 
pneumocytes and a modulating role of monocytes
One possible mechanism for silica-induced fibrosis is that
silica exposure induces a toxic response in the pulmonary
epithelium, leading to a reduction of the cell number and
a subsequent compensatory increase in FGF-2 release
[22,63]. Interestingly, silica induced a marked reduction
in the number of pneumocytes as demonstrated in the
contact co-culture M+P (Figure 6). The silica-induced
decrease of monocytes was less pronounced and only
showed a significant reduction in non-contact co-cultures
at the highest silica-concentration. In accordance with the
hypothesis proposed above, our data showed a negative
correlation between silica-induced loss of pneumocytes
and FGF-2 release (Figure 8A). The relationship between
cell toxicity and a FGF-2 response, however, needs to be
further elucidated.
The present study showed that the FGF-2 release from
pneumocytes was reduced in the contact co-cultures with
monocytes. Thus, FGF-2 levels in silica-exposed M+P/E
co-cultures were lower than in P/E co-cultures. One expla-
nation is that FGF-2 may be bound to molecules released
and/or expressed on the cell surface, including molecules
in extracellular matrix [26]. The monocytes may express
and release the FGF-2-binding protein PTX3, or release
factors that trigger the release of PTX3 from both alveolar
epithelial cells and endothelial cells and thereby modu-
late FGF-2 bioavailability, stability or local concentrations
[26,35,36]. In support of this, silica was shown to induce
PTX3 release from M+P co-cultures (Figure 9). An alterna-
tive explanation to the reduced FGF-2 release from
exposed pneumocytes in contact with monocytes might
be caused by increased release of surfactant or the increase
in number of cells per cm2, as indicated above for IL-8.
The role of IL-1β and TNF-α in FGF-2 release in the co-
cultures
Since it has been shown that IL-1β and TNF-α may be
involved in FGF-2 release [58], and we have shown that
silica induces the release of these cytokines in co-cultures
[41], we studied how antagonists against these agents and
treatment with exogenous IL-1β, affected the silica-
induced FGF-2 release, and the relationship to changes in
the pneumocyte number. The experiments did not reveal
any reduction in FGF-2 release upon IL-1ra and aTNF-α
treatment in any of the lung cell co-cultures (Figure 5).
These data suggest that neither IL-1β nor TNF-α are
directly involved in the regulation of silica-induced FGF-2
synthesis in the lung cell co-cultures. However, adding IL-
1β seemed to reduce both basal and silica-induced release
of FGF-2 in the co-cultures (Figure 7B), indicating that IL-
1β might indirectly affect FGF-2 levels in lung cells. Sev-
eral mechanisms might be involved. IL-1β has been
reported to increase PTX3 levels in different cells, whichParticle and Fibre Toxicology 2008, 5:16 http://www.particleandfibretoxicology.com/content/5/1/16
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may by glycoprotein binding reduce the bioactivity of
FGF-2 [26,36,64]. In support of this we observed that IL-
1β induced PTX3 (Figure 9B). However, the significant
reduction of PTX3 by IL-1ra did not induce any changes in
the FGF-2 release. This discrepancy may probably be
explained by the method used measuring FGF-2 release
since the capture antibody used to measure FGF-2 by
ELISA may detect both free and PTX3-bound FGF-2.
Alternatively, the observed IL-1β-induced shift towards a
higher cell number of pneumocytes (Figure 7C) and a
marked change in the correlation between cell number
and FGF-2 release (Figure 8) may support a potential role
for IL-1β on changes in cell number and thereby affecting
the FGF-2 release from pneumocytes. This IL-1β-induced
effect on pneumocyte number might be mediated via
modulation of cell survival or proliferation. IL-1β has
been suggested to participate in alveolar epithelial cell
proliferation [9]. In the controls exogenous IL-1β did not
induce any increase in the number of pneumocytes, but
this may be due to pneumocyte contact-dependent inhibi-
tion of proliferation. Other studies have shown that IL-1β
augmented alveolar epithelial repair and caused reduced
apoptosis or increased survival in lung epithelial cells
[10,65]. Furthermore, IL-1β treatment may also facilitate
survival by increased release of antioxidants. The impor-
tance of IL-1β-mediated modulation of silica-induced
FGF-2 response is unclear. It could be speculated that dur-
ing sustained silica exposure in vivo the IL-1β may gradu-
ally be elevated to levels that may protect against further
silica-induced damage to lung cells and thereby lower the
FGF-levels similarly to what is observed upon IL-1β expo-
sure in our co-cultures. In the silica-exposed co-culture the
increase in IL-1β release might have been too delayed or
too low to affect the silica-induced FGF-2 via modulation
of PTX3 or by reduction in pneumocyte numbers.
Conclusion
This study shows that IL-1β seems to be differently
involved in the silica-induced release of IL-8 and FGF-2 in
lung cell cultures. The cellular interactions in the co-cul-
tures influence these responses, with monocytes and
pneumocytes mutually reducing the other cell type's
release of mediators. The silica-induced IL-8 release
involves an IL-1-receptor-mediated mechanism, whereas
the silica-induced FGF-2 release does not, at least not in
this experimental setting. The increased silica-induced lev-
els of FGF-2 were associated with a reduction in the
number of pneumocytes. Both responses were counter-
acted by exogenous IL-1β. Furthermore, the enhanced IL-
8 and FGF-2 responses in co-cultures involving endothe-
lial cells may suggest that both these mediators play a role
in angiogenic processes, and shows the importance of the
mutual interaction between different cell types.
Methods
Cell culture conditions
Contact and non-contact co-cultures were established of
three human cell lines; Human acute monocytic leukemia
cells (THP-1), pneumocytes (A549) and endothelial cells
(HIVE-26 from the Wistar special collection) obtained
from the American Tissue Type Culture Collection (ATCC,
Rockville, MD, USA). The cell lines were grown in culture
flasks in a humidified atmosphere at 37°C and 5% CO2.
Monocytes were grown in RPMI 1640 medium with 2 mM
L-glutamine (Cambrex Bio Science, Verviers, Belgium)
and supplemented with 10% heat-inactivated FBS, 10
mM of N-(2-hydroxyethyl)piperazine-N'-(2-ethanesul-
fonic acid); 4-(2-hydroxyethyl)piperazine-1-ethanesul-
fonic acid (HEPES), 1 mM pyruvic acid (Sigma-Aldrich,
St. Louis, MO, USA) and 0.1% gentamicin (GIBCO, Pais-
ley, UK). Pneumocytes, were cultured in Nutrition Mix-
ture F12 HAM Kaighn's modification (F12K, Sigma-
Aldrich, St. Louis, MO, USA), supplemented with 10%
heat-inactivated FBS (Euroclone, Siziano, Italy), 100 μg/
ml ampicillin (Bristol-Myer Squibb, Bromma, Sweden),
100 μg/ml penicillin/streptomycin (Bio Wittaker™, Walk-
ersville, MD, USA) and 0.25 μg/ml fungizone (Bristol-
Myer Squibb, Middlesex, UK). The endothelial cell growth
medium used was similar to the pneumocytes, but was
additionally supplemented with 100 μg/ml heparin and
0.03 mg/ml endothelial cell growth supplement (ECGS,
no. E2759), and the cells were grown in flasks or wells
pre-coated with 0.1% gelatine. Heparin, ECGS and gela-
tine were obtained from Sigma-Aldrich, St. Louis, MO,
USA.
THP-1 monocytes, A549 pneumocytes and endothelial
cells were cultured in monocultures or in contact or non-
contact co-cultures. The monocytes were cultured in con-
tact with the pneumocytes (M+P) or in non-contact (M/
P). The endothelial cells were cultured in non-contact
with monocytes (M/E) or pneumocytes (P/E). In a triplet
co-culture model, monocytes in contact with pneumo-
cytes were cultured in non-contact with endothelial cells
(M+P/E). Generally, contact is symbolised by "+" and
non-contact by "/". The non-contact co-cultures (M/P, M/
E and P/E) were established by seeding A549 cells or
endothelial cells into 35 mm 6-well plates with growth
area of 9.6 cm2 per well (Corning Incorporated Costar,
NY, USA). The plates were incubated for two to three days
until approximately 70% confluence was achieved. Inserts
added with monocytes (for M/P or M/E co-cultures) or
grown with A549 cells (for the P/E co-culture) were then
placed in the wells. The A549 cells were for the contact co-
cultures M+P and M+P/E and for the non-contact co-cul-
tures with endothelial cells (P/E), seeded on inserts with
growth area of 4.7 cm2 per insert and grown to the same
confluence as in wells. The inserts were equipped with a
permeable membrane (pore size 0.4 μm) and placed intoParticle and Fibre Toxicology 2008, 5:16 http://www.particleandfibretoxicology.com/content/5/1/16
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the 35 mm 6-wells culture dishes (Transwell – clear inserts
for optimal visibility from Corning Incorporated Costar,
NY, USA). THP-1 cells in co-cultures or monocultures
were always seeded in inserts, except for some experi-
ments with contact co-cultures of THP-1 and A549 cells in
wells. One to two hours before starting the experiments
the medium was changed to F12K for all cultures and the
THP-1 cells were eventually added at 0.6 × 106 cells/insert
or 1.2 × 106 cells/well to the respective co-cultures imme-
diately before silica exposure.
Particle exposure
In this study crystalline silica was used at concentrations
(80 and 160 μg/cm2) inducing significant changes in
cytokine release. The exposure time of 43 h was chosen
since an earlier study with M/E co-cultures showed time-
dependent fluctuations in pro-inflammatory mediators
indicating this time point to be an appropriate exposure
time for studying silica-induced mediator release in co-
cultures with monocytes [41]. The commercially available
crystalline silica particle Min-U-sil® 5 Ground Silica was
purchased from U.S. Silica Company, Berkeley Springs,
WV, USA. Min-U-sil® 5 is a high purity, natural crystalline
silica. According to the manufacturer, this ground silica
consists of at least 98% SiO2 and has a size distribution
with typically 96% passing 5 μm and a median diameter
of 1.6 μm. The crystalline silica particles solutions (5 mg/
ml) were prepared using 30 min sonication. The sonicated
particles were added to the cell cultures as previously
described by Hetland et al. (2000) [66], except for the
delayed addition of FBS (see below). This particle did not
contain any detectable amount of endotoxins in contrast
to particle samples from other sources [67]. Endotoxins
were measured in aqueous extracts by kinetic limulus
amebocyte lysate assay, Kinetic-QCL®, Cambrex, Walkers-
ville, MD, USA) with a detection limit of 0.005 U/mg.
Only THP-1 and/or A549 cells in mono- or co-cultures
were exposed to particles. In the contact co-cultures (M+P
and M+P/E) both THP-1 and A549 was exposed to parti-
cles, but in non-contact co-cultures (M/P, M/E and P/E)
only the THP-1 cells or A549 cells placed in inserts were
exposed. Thus, the endothelial cells in mono- or co-cul-
tures were not exposed to silica. To allow for particle cell
interactions in the absence of serum proteins, the cells
were cultured in FBS-free medium for 2 h in the presence
of silica, then 10% FBS was added. In all experiments the
wells contained 2.4 ml of medium (including FBS), start-
ing with an equal distribution of medium into the inserts
and wells below. After 43 h the medium was collected and
centrifuged twice for 10 min to remove cells (300 g) and
particles (8000 g). Supernatants were stored at -70°C
until cytokine analysis. In some experiments the number
of monocytes and pneumocytes was counted. The silica
concentrations used for exposure are shown in figures or
legends and the silica concentrations/cm2 were similar in
contact and non-contact co-cultures, and not adjusted for
different cell number.
Inhibition of TNF-α and IL-1 receptor
In order to examine whether the particle-induced inflam-
matory responses were mediated via TNF-α or IL-1, co-
cultures were pre-treated with the therapeutic inhibitors
anti-TNF-α (Infliximab, Remicade™, Scherling-Plough,
Stockholm, Sweden, 10 μg/ml) or IL-1ra (Anakinra, Kin-
ret™, Amgen, BV, Breda, The Netherlands, 15 μg/ml). The
anti-TNF-α inactivates both membrane-bound and solu-
ble TNF-α. These therapeutic inhibitors were applied to
the medium separately or in combination 30 min before
exposure to silica. To assure sufficient concentrations dur-
ing the entire exposure time, the inhibitors were added a
second time at 20 h. Supernatants were collected for anal-
ysis of TNF-α, IL-1β, IL-1α, IL-8 and FGF-2 at 43 h. The
viability of the two cell lines (M and P) was not signifi-
cantly affected by any of the antagonists (data not
shown).
Effect of recombinant IL-1β in co-cultures
To study the effect of IL-1β on the release of IL-8 and FGF-
2 from silica-exposed contact co-cultures of monocytes
and pneumocytes, different concentrations (10 – 100 pg/
ml) of recombinant IL-1β (from Biosource International,
Camarillo, CA, USA) were added once to the medium 30
min before silica exposure. The cytokine levels were meas-
ured after 43 h.
Analysis of mediators
Enzyme-linked immunosorbent assay (ELISA) kits (Cyto-
Sets™, Biosource International, Camarillo, CA, USA or
DuoSet ELISA kits, R&D Systems Inc. Minneapolis, MN,
USA) were used to determine the levels of the pro-inflam-
matory cytokines TNF-α, IL-1α, IL-1β, the chemokine IL-
8, the protein PTX3 and the concentration of FGF-2. All
ELISA kits were used according to the manufacturer's
manual. The increase in colour intensity was quantified
using a plate reader with software (Revelation Version
4.22, Thermo Labsystems, Chantilly, VA, USA).
Cytotoxicity and number of monocytes and pneumocytes
To investigate changes in cell viability, non-adherent
monocytes were removed with the supernatant and col-
lected by centrifugation. The pneumocytes were detached
from the wells by incubation with 0.025% of trypsin
(Sigma-Aldrich, St. Louis, MO, USA) at 37°C in 4 min.
Both cell types were stained with trypan blue for 3 min,
and the number of viable cells counted in a Bürker cham-
ber. The release of lactate dehydrogenase (LDH) from the
cytosol of damaged cells into the culture medium was
used as a measure for the particle-induced cytotoxicity.
LDH was measured in supernatants from contact (M+P)
and non-contact (M/P) co-cultures using a colorimetricParticle and Fibre Toxicology 2008, 5:16 http://www.particleandfibretoxicology.com/content/5/1/16
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assay (Cytotoxicity detection kit, Roche, Basel, Switzer-
land) supplemented with a LDH standard with maximum
concentration of 250 mU/ml (Roche).
Statistical analysis
All values are given as mean ± standard error of the mean
(SEM). The release of mediators is in some figures
expressed as % of max since the released levels, but not the
relative response between cultures varied in each experi-
ment, thereby causing difficulties in revealing statistically
significant changes between groups. The mean ± SEM of
max in pg/ml is given in legends of figures. The statistical
analysis was performed in GraphPad Prism (version 4.03
for Windows, GraphPad Software, San Diego, California,
USA, http://www.graphpad.com). Two-way ANOVA was
used to analyse all data sets. In the majority of the data
sets, the interaction between row and column factors was
significant. Since statisticians recommend ignoring the
results from row and column tests under such conditions,
post-tests with Bonferroni correction were used to com-
pare groups. To fulfil the assumption of equal standard
deviations of all sets of replicates, some data were log-
transformed before performing ANOVA, and if data levels
varied too much between experiments repeated measured
ANOVA was applied [68]. Furthermore, univariate linear
regression and correlation analysis were used to assess if
cell number could explain the changes in release of FGF-
2. A p value < 0.05 was considered to be significant.
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